Upcoming Webinars

Register Here!


GastroPlus® v9.8.1 DDI Standards Update and Documentation Project

IPFsym™, a platform to support the development of effective treatments for IPF patients

Watch Past Webinars

Introducing, IPFsym™ the QSP modeling software for idiopathic pulmonary fibrosis

IPFsym® is a mechanistic, mathematical model for QSP of idiopathic pulmonary fibrosis (IPF) that can be used to predict efficacy for potential treatments.

Stream Download

Culture & Conversation – The accelerator pedal for innovation…

The central idea behind the “learn and confirm” paradigm is to emphasize the learning part of R&D and then intelligently apply what has been learned to the design of clinical trials.

Stream Download

Best Practices for Membrane & Biphasic In Vitro Dissolution with DDDPlus™ & GastroPlus®

DDDPlus is a state-of-the-art simulation platform for in vitro dissolution.

Stream Download

Simulx Webinar: Optimizing Sample Size of a Phase III trial

What if we could reduce the size of a phase III study from 400 to 80 subjects and make it twice as short? Thanks to model-informed clinical trial design, it's possible!


NAFLDsym Application Showcase: Key Examples of NAFLDsym Use within Drug Development

NAFLDsym is a quantitative systems pharmacology (QSP) modeling software to support the development of treatments for non-alcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH).

Stream Download

ADMET Predictor® 10.2 (APX.2): Machine learning platform for ADMET modeling with extended capabilities for discovery PBPK

Stream Download

DILIsym® Applications in Drug Development – Perspectives from 2 Pharma Industry Executives & an Experienced Consultant

What do NURTEC™ ODT, TURALIO®, lixivaptan, solithromycin, JYNARQUE®, VEKLURI®, and UBRELVY® have in common?

Stream Download

Modeling and Simulation of a parent-metabolite-PD datatset (Spring School challenge solution)

Whether you have participated to our Spring School and its modeling challenge or not, this webinar is for you!


Human-on-a-Chip combined with PBPK modeling for in vitro/in vivo PK/PD extrapolation

Human-on-a-Chip (HoaC) systems are becoming valuable tools to study, understand disease physiology, and expand the prediction of pharmacodynamic effects before first-in-human studies. They can also be used to evaluate the toxic effects of compounds in non-pharma industries where these effects cannot be examined in vivo.

Stream Download

Early assessment of PK properties using ADMET Predictor® HTPK Simulation Technology

Physiologically-based pharmacokinetic (PBPK) modeling, combined with in vitro and in vivo extrapolation (IVIVE) approaches...

Stream Download